NextCure, Inc.NXTCNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank50
3Y CAGR-9.0%
5Y CAGR+27.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-9.0%/yr
vs +34.5%/yr prior
5Y CAGR
+27.4%/yr
Recent deceleration
Acceleration
-43.5pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
3.4x
Strong expansion
Streak
3 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $57.25M | -4.2% |
| 2024 | $59.75M | -11.7% |
| 2023 | $67.64M | -10.9% |
| 2022 | $75.91M | +7.3% |
| 2021 | $70.77M | +315.1% |
| 2020 | $17.05M | +77.4% |
| 2019 | $9.61M | -58.6% |
| 2018 | $23.20M | +49.2% |
| 2017 | $15.55M | - |